News tagged with myeloid leukemia
Researchers discover the processes leading to acute myeloid leukemia
Researchers at UC Santa Barbara have discovered a molecular pathway that may explain how a particularly deadly form of cancer develops. The discovery may lead to new cancer therapies that reprogram cells instead ...
Jan 30, 2012 |
5 / 5 (1) |
0
|
Lessons learned from yeast about human leukemia
The trifecta of biological proof is to take a discovery made in a simple model organism like baker's yeast and track down its analogs or homologs in "higher" creatures right up the complexity scale to people, ...
Dec 05, 2011 |
5 / 5 (2) |
0
|
Decoding cancer patients' genomes is powerful diagnostic tool
Two new studies highlight the power of sequencing cancer patients' genomes as a diagnostic tool, helping doctors decide the best course of treatment and researchers identify new cancer susceptibility mutations ...
Apr 19, 2011 |
3 / 5 (1) |
0
|
Audio pioneer Sidney Harman dead at 92
Audio pioneer Sidney Harman, who bought Newsweek magazine last year and merged it with The Daily Beast website, died on Tuesday. He was 92.
Apr 13, 2011 |
not rated yet |
0
Study reveals no impact of age on outcome in chronic myeloid leukemia patients treated with imatinib
While the median age at diagnosis for chronic myeloid leukemia (CML) is over 60 years old and incidence increases dramatically with age,limited data are available about the long-term outcome for older patients treated with i ...
Mar 30, 2011 |
not rated yet |
0
Rituximab and fludarabine produce long-term remissions in CLL
New research shows that a less-toxic combination of a targeted immune-based drug and a chemotherapy drug can produce long-term remissions in some chronic lymphocytic leukemia patients. And it does so without increasing the ...
Feb 25, 2011 |
5 / 5 (2) |
0
Early infusion of donor T cells prevents graft versus host disease in blood cancer patients
For blood cancer patients at high risk of relapse, hematopoietic stem cell transplantation (HSCT), the transplantation of blood-forming stem cells, is one of best options for treatment and a potential cure. Unfortunately, ...
Medicine & Health / Medical research
Feb 03, 2011 |
5 / 5 (1) |
0
'Oncometabolite' linked with widespread alterations in gene expression
A new study finds that a metabolite commonly elevated in brain cancer and leukemia may promote tumorigenesis by altering the expression of a large number of genes. New research, published by Cell Press in ...
Jan 18, 2011 |
not rated yet |
0
New evidence of stem cells' pivotal role in cancer shown
Leukemia patients whose cancers express higher levels of genes associated with cancer stem cells have a significantly poorer prognosis than patients with lower levels of the genes, say researchers at the Stanford University ...
Dec 21, 2010 |
5 / 5 (3) |
1
|
Drugs are safe, active in patients normally ineligible for clinical trial
A two-drug combination is safe and active in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome patients who are usually excluded from clinical trials because they have other illnesses or poor performance ...
Dec 10, 2010 |
not rated yet |
0
Researchers discover key mutation in acute myeloid leukemia
Researchers have discovered mutations in a particular gene that affects the treatment prognosis for some patients with acute myeloid leukemia (AML), an aggressive blood cancer that kills 9,000 Americans annually. ...
Nov 11, 2010 |
3 / 5 (2) |
0
|
Some leukemia patients may be able to safely stop treatment
(PhysOrg.com) -- New medical trials suggest some chronic leukemia patients who are in complete remission may be cured by the standard drug used to treat the condition and can safely discontinue its use.
Oct 21, 2010 |
4.2 / 5 (5) |
1
|
Paper highlight: 'Hi-JAK-ing' cancer by inhibiting Jak2
Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type.
Sep 13, 2010 |
not rated yet |
0
New antibody-combination therapy boosts human lymphoma cure rate in mouse models
(PhysOrg.com) -- More than half of laboratory mice with human non-Hodgkin's lymphoma are cured by a treatment involving just two monoclonal antibodies, according to a new study.
Sep 02, 2010 |
not rated yet |
0
Intensive chemotherapy may be harmful to most older patients with acute myeloid leukemia
The prognosis for nearly three-quarters of elderly patients on intensive chemotherapy for acute myeloid leukemia (AML) is poor, with a median survival of less than six months, according to a study published online today in ...
Jul 29, 2010 |
not rated yet |
0
